tumor-targeting peptideCancer Research Peptides
RGD Peptide (cyclic)
Cyclic Arg-Gly-Asp peptides that target integrin receptors (alphavbeta3/alphavbeta5) overexpressed on tumor vasculature and malignant cells. Used as targeting moieties for drug delivery, imaging, and peptide-drug conjugates.
tumor-targetingintegrin-bindinganti-angiogenicdrug-deliveryimaging
3D Structure
3D Structure
603.68 Da
46 atoms
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
Cyclic Arg-Gly-Asp peptides that target integrin receptors (alphavbeta3/alphavbeta5) overexpressed on tumor vasculature and malignant cells. Used as targeting moieties for drug delivery, imaging, and …